期刊文献+

HIV-1逆转录酶非核苷类抑制剂MKC分子结合位点的理论研究 被引量:1

A Theoretical Study of Non-nucleoside Inhibitor MKC Molecular Binding Sites at the HIV-1 Reverse Transcriptase
下载PDF
导出
摘要 1RT1蛋白是一个HIV-1逆转录酶核心蛋白,是抑制剂药物分子的作用靶点.非核苷类抑制剂MKC分子是1RT1蛋白中的配体分子.采用量子力学密度泛函理论,B3LYP计算方法,结合6-31G(d,p)基组,逐个计算MKC分子与其周围半径0.7 nm结构范围内的34个氨基酸残基相互作用和结合能,发现在1RT1蛋白中103Lys残基是MKC分子的结合作用位点,结合能值为-46.73 kJ.mol-1.该结合位点的发现将为进一步设计和寻找抗HIV-1逆转录酶抑制剂药物分子提供一些理论基础. 1RT1 protein is a core -structure protein of HIV-1 reverse transeriptase, which is a target to be used for controlling Aids by non-nucleoside inhibitors. The MKC molecule, a non-nucleoside inhibitor, is a ligand molecule extracted from 1 RT1 protein. The paper adopts the B3LYP/6-31 G(d, p) method to explore the interaction and binding energies between MKC molecule and every single of 34 amino acid residues arranged in the sphere of 0.7nm radius around MKC molecule. The results obtained indicate that 103Lys residue is a binding site of 1RT1 protein for MKC molecule with its binding energy of -46.73kJ·mol^-1. The proved binding site will help provide some theoretical foundation to explore and design the HIV-1 reverse transcriptase inhibitor drug molecules.
出处 《云南民族大学学报(自然科学版)》 CAS 2009年第1期37-40,共4页 Journal of Yunnan Minzu University:Natural Sciences Edition
基金 国家自然科学基金资助项目(29763002) 云南省后备人才科研基金资助项目(2006PY01-29)
关键词 HIV-1 1RT1蛋白 MKC 结合位点 DFT HIV-1 1RT1 protein MKC binding site DFT
  • 相关文献

参考文献10

  • 1CLAVEL R, GUETARD D, BRUN - VEZINET R, et al. Isolation of a New Human Retrovirus from West African Patients with AIDS [ J ]. Science, 1986,233 ( 4761 ) : 343 - 346.
  • 2COX T M, SCICLAIR J. Molecular Biology In Medicine[ M]. Beijing:Science Press, 2000.
  • 3DE CLERCQ E. The Role of Non - nucleoside Reverse Transcriptase Inhibitors (NNIs) in the Therapy of HIV - 1 Infection [J]. Antiviral Research, 1998,38:153 - 179.
  • 4ESNOUF R M, REN J, ROSS C. Mechanism of Inhibition of HIV - 1 Reverse Transcriptase by Non - nucleoside Inhibitors[ J]. Nature Structural Biollgy, 1995,2:303 - 308.
  • 5MIYASAKA T, TANAKA H, BABA M. A novel Lead for Specific Anti - HIV - 1 Agent: 1 - [(2 - hydroxyethoxy) methyl]- 6 - (phenylthio) Thymine [ J ]. J Med Chem, I989,32:2507 - 2509.
  • 6BABA M, TANAKA H, MIYASAKA T, et al. HEPT Derivatives : 6 - benzyl - 1 - ethoxymethyl - 5 - isopropyluracil ( MKC - 442) [ J ]. Nucleosides, Nucleotides and Nucleic Acide, 1995,14 ( 3 - 5 ) :575 - 583.
  • 7SYBYL Molecular Modeling System, Version 7.2[CP]. Tripos, Inc: St Louis, MO.
  • 8CLARK M, CRAMER R, VAN OPDENBOSH N. Validation of the General Purpose Tripose 5.2 Force Field [ J ]. Comput Chem, 1989,10:982 - 1012.
  • 9HUMPHREY W, DALKE A, SCHULTEN K. VMD - visual Molecular Dynamics [ J ]. Journal of Molecular Graphics, 1996,14 (1) :33 -38.
  • 10FRISCH M J. Gaussian 03, Revision D. 01 [ CP], Gaussian, Ine: Wallingford CT, 2004.

同被引文献42

  • 1Kijas,J.W.; Cideciyan,A.V.; Aleman,T.S.; Pianta,M.J.,Pearce-Kelling,S.E.; Miller,B.J.; Jacobson,S.G.; Aguirre,G.D.;Acland,G.M.Proc.Natl.Acad.Sci.U.S.A.,2002,99:6328
  • 2Sekharan,S.; Sugihara,M.; Weingart,O.; Okada,T.; Buss,V.J.Ant Chem.Soc.,2007,129:1052
  • 3Humphries,P.; Kenna,P.; Farrar,J.G.Science,1992,256:804
  • 4Berson,E.L.Proc.Natl.Acad.Sci.U.S.A.,1996,93:4526
  • 5Nathans,J.Biochemistry,1992,31:4923
  • 6Cohen,G.B.; Oprian,D.D.; Robinson,P.R.Biochemistry,1992,31:12592
  • 7Rim,J.; Oprian,D.D.Biochemistry,1995,34:11938
  • 8Cohen,G.B.; Yang,T.; Robinson,P.R.; Oprian,D.D.Biochemistry,1993,32:6111
  • 9Dryja,T.P.; McGee,T.L.; Reichel,E.; Hahn,L.B.; Cowley,G.S.;Yandell,D.W.; Sandberg,M.A.; Berson,E.L.Nature,1990,343:364
  • 10Tsutsui,K.; Imai,H.; Shichida,Y.Biochemistry,2008,47:10830

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部